TY - JOUR
T1 - Impact of medical comorbidity in biomarker discovery for major depressive disorder
AU - Czysz, Andrew
N1 - Publisher Copyright:
© 2020, Slack Incorporated. All rights reserved.
PY - 2020
Y1 - 2020
N2 - The interaction between major depressive disorder (MDD) and other medical conditions is increasingly recognized as an important factor for clinical management and for biomarker development. Many common medical conditions have a bidirectional epidemiologic relationship with MDD that may have roots in shared pathophysiologic, environmental, and psychosocial factors. Furthermore, depression is increasingly recognized as a systemic disease. Understanding this relationship is challenging because of the immense variability between patients with MDD and also within other medical disorders themselves. This includes not only specific symptoms, but also disease severity, duration, disability, and treatment resistance.
AB - The interaction between major depressive disorder (MDD) and other medical conditions is increasingly recognized as an important factor for clinical management and for biomarker development. Many common medical conditions have a bidirectional epidemiologic relationship with MDD that may have roots in shared pathophysiologic, environmental, and psychosocial factors. Furthermore, depression is increasingly recognized as a systemic disease. Understanding this relationship is challenging because of the immense variability between patients with MDD and also within other medical disorders themselves. This includes not only specific symptoms, but also disease severity, duration, disability, and treatment resistance.
UR - http://www.scopus.com/inward/record.url?scp=85090738316&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85090738316&partnerID=8YFLogxK
U2 - 10.3928/00485713-20200507-02
DO - 10.3928/00485713-20200507-02
M3 - Article
AN - SCOPUS:85090738316
SN - 0048-5713
VL - 50
SP - 239
EP - 243
JO - Psychiatric Annals
JF - Psychiatric Annals
IS - 6
ER -